Emoxypine Succinate

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

Emoxypine Succinate 是一种抗氧化剂。

Emoxypine Succinate is an antioxidant.?(In Vitro):Emoxypine succinate shows reactive oxygen species overproduction and disruption of the mitochondrial inner membrane due to the decreasing of transmembrane potential.(In Vivo):Emoxypine succinate (i.p.; 40 mg/kg; 1 time per day, 14 days) decreases the production of reactive oxygen species, mitochondrial transmembrane potential percentage of leukocyte and the percentage of FITC Annexin V- positive cells of leukocyte suspension.

Emoxypine succinate shows reactive oxygen species overproduction and disruption of the mitochondrial inner membrane due to the decreasing of transmembrane potential.

Emoxypine succinate (i.p.; 40 mg/kg; 1 time per day, 14 days) decreases the production of reactive oxygen species, mitochondrial transmembrane potential percentage of leukocyte and the percentage of FITC Annexin V- positive cells of leukocyte suspension. Animal Model:Rats Dosage:40 mg/kg Administration:Intraperitoneal, 1 time per day, 14 days Result:Significantly increased the percentage of Annexin V-positive cells, reduced the apoptotic percentage of white blood cells and decreased the production of reactive oxygen species by leukocytes.

——

Others

Other Targets

others

Cardiovascular Disease

Ischemic Stroke

127464-43-1

255.27

C8H11NO.C4H6O4

>98% (HPLC)

In Vitro:?H2O : 250 mg/mL (979.36 mM)

CCc1nc(C)ccc1O.O=C(O)CCC(=O)O

2-Ethyl-6-methylpyridin-3-ol Succinate

(-20℃)

With Ice Pack

≥ 2 years